ArticleEuropean urology oncology2019

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Marco Bandini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.